We invent devices, and we prove them.
Myelin Cloud (Shenzhen) Technology is a medical-technology R&D company. We invent original medical devices, protect them with layered patents, develop the consumables and data platforms around them, and validate them with objective clinical data. Our first device is Histo-Cooling.
Where we started
Myelin Cloud was founded on a simple observation: medicine is full of conditions we treat but cannot measure well. The objective evidence, the endpoint a regulator will trust, is missing precisely where it matters most. We build the devices that close that gap.
Our first took aim at one of the hardest problems in dermatology to quantify, nocturnal itch, where trials still lean on the score a patient gives from next-morning memory. Rather than build a finer questionnaire, we built a device that records scratching through the night and responds when it happens. That method (measure objectively, intervene safely, record everything) is how we build every device that follows.
What we build
We invent original medical devices, protect each one with layered patents, develop the consumables and data platforms that turn it into a repeatable clinical protocol, and validate it with objective clinical evidence. Every product runs through the same model. Histo-Cooling is the first: a fully sealed, hospital-disinfectable device that integrates scratch monitoring, active cooling, and clinical-grade data recording into one closed loop.
How we work
Evidence before claims
We measure a phenomenon objectively before we draw conclusions, and we claim only what the data supports.
Data sovereignty by design
Our devices keep data local, signed on-device, and exported only when the user chooses. Privacy and data localization are designed in, not bolted on.
Built for clinical trust
We engineer every device so its data holds up to audit, blinding, and regulatory review, not just its own study.
A combination moat
Durability comes from the combination of patents, clinical data, clearance, and partnerships, not any single link.